NUVB
USDNuvation Bio Inc. Class A Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$5.150
Máximo
$5.190
Mínimo
$3.920
Volume
6.20M
Fundamentos da empresa
Capitalização de mercado
1.7B
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
7.11M
Bolsa de valores
NYQ
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.